Trident Lifeline Limited (BOM:543616)

India flag India · Delayed Price · Currency is INR
259.75
-8.20 (-3.06%)
At close: Mar 9, 2026
-3.13%
Market Cap 3.10B
Revenue (ttm) 1.27B
Net Income (ttm) 159.28M
Shares Out 11.93M
EPS (ttm) 13.78
PE Ratio 18.85
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,800
Average Volume 11,400
Open 248.10
Previous Close 267.95
Day's Range 248.00 - 259.75
52-Week Range 237.00 - 328.00
Beta -0.31
RSI 46.01
Earnings Date Feb 19, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target... [Read more]

Industry Pharmaceutical Preparations
Founded 2014
Employees 74
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543616
Full Company Profile

Financial Performance

In fiscal year 2025, Trident Lifeline's revenue was 869.65 million, an increase of 94.86% compared to the previous year's 446.29 million. Earnings were 117.48 million, an increase of 85.18%.

Financial Statements

News

There is no news available yet.